Alfred J. Novak
CIK: 0001388862
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
KTTA
Pasithea Therapeutics Corp.
Director
Discretionary Trading P&L
Holdings
About Novak Alfred J
Novak Alfred J (SEC CIK 0001388862) files insider reports with the SEC as Director of Pasithea Therapeutics Corp. (KTTA).
Signal8 holds 2 ownership filings by Novak Alfred J, all Form 4s, filed between Oct 27, 2025 and May 5, 2026. Those filings report 2 transactions, from Oct 24, 2025 to May 1, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Novak Alfred J's filings is in MIAMI BEACH, FL.
Recent filings by Novak Alfred J
Other insiders filing for Pasithea Therapeutics Corp. (KTTA)
- Coastlands Capital LP, 10% Owner
- Marques Tiago, Chief Executive Officer
- STEINMAN LAWRENCE, Director
- Dumesnil Simon, Director
- Schneiderman Daniel H, Chief Financial Officer
- Krishnan Kartik, Chief Medical Officer